Patent · US Active

Gene therapy using transposon-based vectors

US8236294B2 · kind B2 · utility

10Cited by

78References

23Claims

0Family size

Assignees

BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE · US
TransGenRx, Inc. · US

Inventors

Richard K. Cooper · Baton Rouge, US
Frederick M. Enright · Baton Rouge, US
William C. Fioretti · Colleyville, US

Key dates

Filing date	Nov 8, 2010
Grant date	Aug 7, 2012
Priority date	—
Expiry date	Nov 8, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2800/90
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods and compositions are presented for the administration of transposon-based vectors to an animal or human to provide gene therapy to the animal or human.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.